12:00 AM
 | 
Jul 15, 2013
 |  BC Week In Review  |  Clinical News  |  Regulatory

Tamiflu oseltamivir regulatory update

Chugai said it extended the shelf-life for the capsule formulation of influenza drug Tamiflu oseltamivir to 10 years from 7 years in Japan based...

Read the full 96 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >